RTI developed a new cost-effectiveness analysis of repeat HIV testing during pregnancy to inform updated guidelines for repeat HIV testing during pregnancy. The team constructed a decision tree model to evaluate the cost-effectiveness of universal, voluntary repeat HIV testing during the third trimester of pregnancy. Using a societal perspective, RTI estimated the incremental costs and benefits of a second HIV test during the third trimester relative to the status quo of a single HIV test early in pregnancy for all women. The team also reported on the costs and benefits of early HIV detection in pregnant women and averted transmissions for their sexual partners resulting from repeat testing during pregnancy. RTI staff conducted sensitivity analyses to determine the impact of uncertainty in parameter values on the cost-effectiveness ratio and performed a threshold analysis to determine the HIV incidence rate at which costs per life-year saved reached $100,000.
Project Description
Project Partners
Center for Disease Control National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Project Open
Closed
Project Services
Countries